It is expected that the psoriasis treatment market size will grow at the rate of 7.3% CAGR in the forecasted period and is expected to reach USD 13.1 billion during the forecast period. The social stigma and discomfort that is associated with psoriasis is expected to promote swift market growth. Valued at USD 7 Bn at the beginning of 2016, the global market is expected to witness increased revenue which results in an approximate evaluation of over USD 10 bn by the end of the assessment period.
Rising awareness and screening for psoriasis is the leading factor driving growth in the demand for psoriasis treatment. This chronic condition is exacerbated by several factors which can vary from patient to patient, thus further increasing the demand for appropriate and effective treatment options. Increasing exposure to chemicals and polluted environments have resulted in an increase in the diagnosis of psoriasis. Presently, all treatment options are temporary in nature or need ongoing patient involvement with no concrete cure. Drugs for psoriasis treatment carry a high cost which will hamper market growth. However, increasing adoptions of alternative psoriasis treatments, and the race among market players to develop an effective psoriasis treatment solution will lead to market opportunities.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/2769
Market Segmentation
The global psoriasis treatment market is segmented in MRFR's competitive analysis on the basis of mechanism of action, route of administration, drug types, and region. Based on mechanism of action, the market is segmented into interleukin blockers, phosphodiesterase inhibitors, TNF inhibitors, and others.
By route of administration, the market is divided between oral, injectable, and topical. Oral treatment options are highly popular and capture around 40% of the global market.
On the basis of drug types, the market is segmented into biologics and small molecules.
Globally, the market is divided into the Americas, Europe, Asia-Pacific (APAC), and the Middle East and Africa.
Regional Analysis
Due to the presence of North America, the Americas account for the largest share of the global market. The presence of several market players and a high patient population afflicted with psoriasis is expected to lead to increased revenue generated for market growth. Moreover, the awareness about this condition is quite high in the region and has led to an increased demand for effective treatment options. Increasing RD activities to develop a long-term solution for psoriasis is expected to facilitate market expansion opportunities.
Meanwhile, the Asia Pacific is the fastest growing region due to the swiftly developing healthcare sector and the growing awareness regarding conditions like psoriasis which has resulted in increased demand. The affinity for natural skin care methods is expected to reveal effective alternate treatment strategies that may assist future market growth.
Key Players
Market leaders who participate in the competitive landscape of the global psoriasis treatment market include Eli Lilly, Novartis International AG, Johnson Johnson, Pfizer Inc., Merck and Co Inc., Amgen and AbbVie.
Latest Industry News
Eli Lilly Company in Korea has received government approval from the Ministry of Health Welfare for the reimbursement for its psoriasis treatment drug Taltz.
Access Report @ https://www.marketresearchfuture.com/reports/psoriasis-treatment-market-2769
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
